Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Universe Pharmaceuticals (UPC) Equity Ratio (2021 - 2025)

Universe Pharmaceuticals' Equity Ratio history spans 4 years, with the latest figure at 0.0 for Q3 2024.

  • For Q3 2024, Equity Ratio fell 100.0% year-over-year to 0.0; the TTM value through Sep 2024 reached 0.0, down 100.0%, while the annual FY2024 figure was 0.0, 100.0% down from the prior year.
  • Equity Ratio for Q3 2024 was 0.0 at Universe Pharmaceuticals, down from 670.35 in the prior quarter.
  • Across five years, Equity Ratio topped out at 670.35 in Q3 2023 and bottomed at 0.0 in Q3 2024.
  • The 4-year median for Equity Ratio is 297.03 (2021), against an average of 316.1.
  • The largest annual shift saw Equity Ratio skyrocketed 88474.92% in 2022 before it tumbled 100.0% in 2024.
  • A 4-year view of Equity Ratio shows it stood at 0.67 in 2021, then surged by 88474.92% to 593.39 in 2022, then grew by 12.97% to 670.35 in 2023, then plummeted by 100.0% to 0.0 in 2024.
  • Per Business Quant, the three most recent readings for UPC's Equity Ratio are 0.0 (Q3 2024), 670.35 (Q3 2023), and 593.39 (Q3 2022).